Human Papilloma Virus, Risk Factors and Sequelae: How much do Female Adolescents in Port Harcourt Metropolis know?
Keywords:
Human Papillomavirus, cervical cancer, adolescents, Port HarcourtAbstract
Background: Human Papilloma virus (HPV) infection is the most common viral infection of the genital tract; is sexually transmitted with the highest rates observed in young women. This study assessed the level of knowledge of HPV and cervical cancer among adolescent girls in Port Harcourt metropolis, Nigeria.
Methodology: A cross-sectional survey among 328 in-school female secondary school students aged 9 - 19 years, selected via multi-stage sampling. Information on socio-demographics, knowledge of HPV and cervical cancer and sexual history were collected using a self-administered, semi-structured questionnaire. Data was analyzed using SPSS version 23 and Chi square test was used to establish associations.
Results: Only 38.2% and 30% had heard of cervical cancer and HPV respectively; the media being the most common source. Knowledge oftransmission, risk factors, sequelae and prevention of infection was poor (75%). About 20.2% were aware of the causal association between HPV infection and cervical cancer. Some (3.1%) were sexually exposed and practiced unprotected sexual intercourse. Median age at sexual debut was 11 years. Older and private school students (15-19years) had better knowledge
Conclusion: The level of knowledge of HPV, cervical cancer, their association and risk factors, among adolescent girls in Port Harcourt metropolis is poor. Some adolescents engage in sexual practices that put them at risk for HPV infection. Social media and upper primary and secondary school-based approach to HPV health promotion should be explored to provide detailed adolescent-friendly information to guide in prevention of HPV infection and cervical cancer
References
Nejo YT, Olaleye DO, Odaibo GN. Prevalence and Risk Factors for Genital Human PapillomavirusInfections Among Women in Southwest Nigeria. Archives of basic and applied medicine. 2018 Feb;6(1):105-12.
Toh ZQ, Kosasih J, Russell FM, Garland SM, Mulholland EK, Licciardi PV. Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus. Infection and drug resistance. 2019; 12:1951.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2018 Nov;68(6):394-42
.4Kennedy NT, Ikechukwu D, Goddy B. Risk factors and distribution of oncogenic strains of human papilloma virus in women presenting for cervical cancer screening inPort Harcourt, Nigeria. Pan African Medical Journal. 2016 Jul 4;23(1).
Centers for Disease Control and Prevention. STD Curriculum for Clinical Educators. Genital Human papillomavirus. 2013:1-37.
Vinodhini K, Shanmughapriya S, Das BC, Natarajaseenivasan K. Prevalence and risk factors of HPV infection among women from various provinces of the world. Archives of gynecology and obstetrics. 2012 Mar;285(3):771-7.
Cervantes JL, Doan AH. Discrepancies in the evaluation of the safety of the human papillomavirus The level of knowledge of Human Papilloma virus, vaccine. Memórias do Instituto Oswaldo Cruz. 2018 May 28;113
Doufekas K, Achampong Y, Olaitan A. Prevention of Cervical Cancer. InUterine Cervical Cancer 2019 (pp. 17-29). Springer, Cham.
World Health Organization, 2021. Human Papilloma virus vaccines (HPV).Available at https://www.who.int/teams/immunization-vaccines-and-biologicals/diseases/human-Papilloma virus-vaccines-(HPV). Accessed October 7th, 2021
Grm HS, Bergant M, Banks L. Human papillomavirus infection, cancer & therapy. Indian Journal of Medical Research. 2009 Sep 1;130(3):277.
Bonnez, W. Human Papilloma virus. InVaccines for Biodefense and Emerging and Neglected Diseases; Alan, D.T., Barrett, L.R.S., Eds.; Academic Press: Cambridge, MA, USA, 2009; pp. 469–496.
ICO/IARC Information Centre on HPV and Cancer, 2019. Nigeria: Human Papilloma virus and Related Cancers, Fact Sheet 2019. Available at https://www.hpvcentre.net/statistics/reports/NGA_FS.pdf. Accessed 4th November 2020
Mahomed K, Evans D, Sauls C, Richter K, Smith J, Firnhaber C. Human papillomavirus (HPV) testing on self-collected specimens: perceptions among HIV positive women attending rural and urban clinics in South Africa. The Pan African medical journal. 2014;17.
Schmitt M, Depuydt C, Benoy I, Bogers J, Antoine J, Arbyn M, Pawlita M, VALGENT Study Group.
Prevalence and viral load of 51 genital human papillomavirus types and three subtypes. International journal of cancer. 2013 May 15;132(10):2395-403.
Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. Journal of clinical pathology. 2002 Apr 1;55(4):244-65.
Bardají A, Mindu C, Augusto OJ, Casellas A, Cambaco O, Simbine E, Matsinhe G, Macete E, Menéndez C, Sevene E, Munguambe K. Awareness of cervical cancer and willingness to be vaccinated against human papillomavirus in Mozambican adolescent girls. Papillomavirus Research. 2018 Jun 1;5:156-62.
World Health Organization, 2019. Human Papilloma virus (HPV) and Cervical cancer. Available at https://www.who.int/news-room/fact-sheets/detail/human-Papilloma virus-(hpv)-and-cervical-cancer. Accessed October 25th, 2021.
ICO/IARC Information Centre on HPV and Cancer, 2021. Nigeria: Human Papilloma virus and Related Cancers, Fact Sheet 2021. Available at https://hpvcentre.net/statistics/reports/NGA_FS.pdf. Accessed 15th October, 2021.
Schiffman M, Wentzensen N. Human papillomavirus infection and the multistage carcinogenesis of cervical cancer. Cancer epidemiology, biomarkers & prevention. 2013 Apr;22(4):553-60.
Kjaer SK, Chackerian B, Van Den Brule AJ, Svare EI, Paull G, Walbomers JM, Schiller JT, Bock JE, Sherman ME, Lowy DR, Meijer CL. High-risk human papillomavirus is sexually transmitted: Evidence from a follow-up study of virgins starting sexual activity (Intercourse). Cancer Epidemiology Biomarkers and Prevention. 2001;10(2):101-6.
Alex-Hart BA, Okagua J, Opara PI. Sexual behaviours of secondary school students in Port Harcourt.Journal of Advances in Medicine and Medical Research. 2015;325-334.
Okonta PI. Adolescent sexual and reproductive health in the Niger Delta region of Nigeria-Issues and challenges. African journal of reproductive health. 2007 Apr 1;11(1):113-24.
Ojule IN, Anika IE. Human Papilloma Virus Transmission: Knowledge and Uptake of HPV Vaccine Among In-School Adolescent Girls in South-South Nigeria. International Journal of tropical disease & Health. 2020;41(8): 25-37
Saha A, Chaudhury AN, Bhowmik P, Chatterjee R. Awareness of cervical cancer among female students of premier colleges in Kolkata, India. Asian Pac J Cancer Prev. 2010 Jan 1;11(4):1085-90.
Turiho AK, Muhwezi WW, OkelloES, Tumwesigye NM, Banura C, Katahoire AR. Human papillomavirus (HPV) vaccination and adolescent girls' knowledge and sexuality in Western Uganda: A comparative cross-sectional study. PloS one. 2015 Sep 1;10(9):e0137094.
Sadoh AE, Okonkwo C, Nwaneri DU,Ogboghodo MB, Eregie C, Oviawe O, Famuyiwa MO. Effect of peer education on knowledge of human papilloma virus and cervical cancer among female adolescent students in Benin City, Nigeria. Annals of global health. 2018;84(1):121.
Ifediora CO, Azuike EC. Knowledge and attitudes about cervical cancer and its prevention among female secondary school students in Nigeria. Tropical Medicine & International Health. 2018 Jul;23(7):714-23.
Oboro IL, Athanasius BP. Awareness of Cervical Cancer Screening and Prevention among Students of a Tertiary Institution in Southern Nigeria. Journal of cancer and tumor international. 2020;10 (1), 26-32
Mburu A, Itsura P, Mabeya H, Kaaria A, Brown DR. Knowledge of cervical cancer and acceptability of prevention strategies among human Papillomavirus-Vaccinated and human Papillomavirus-Unvaccinated adolescent women in Eldoret, Kenya. BioResearch open access. 2019 Aug 20;8(1):139-45.
Ahlawat P, Batra N, Sharma P, Kumar S, Kumar A. Knowledge and attitude of adolescent girlsand their mothers regarding Cervical Cancer: a community-based cross-sectional study. Journal of Mid-life Health. 2018 Jul;9(3):145.
Lee A, Ho M, Cheung CKM, Keung VMW. Factors influencing adolescent girls’ decision in initiation for human Papilloma virus vaccination: a cross-sectional study in Hong Kong.BMC public health.2014;14(1):1-10.
Navarro-Illana P, Diez-Domingo J, Navarro-Illana E, Tuells J, Alemán S, Puig-Barberá J. Knowledge and attitudes of Spanish adolescent girls towards human papillomavirus infection: where to intervene to improve vaccination coverage. BMC public health. 2014 Dec;14(1):1-8.
Ozyer S, Uzunlar O, Ozler S, Kaymak O, Baser E, Gungor T, Mollamahmutoglu L. Awareness of Turkish female adolescents and young women about HPV and their attitudes towards HPV vaccination. Asian Pacific Journal of cancer prevention. 2013;14(8):4877-81.
Bodajko-Grochowska A, Bednarek A, Markut-Miotła E, Zarzycka D. Knowledge of cervical cancer prevention among teenagers.Cancer Treatment and Research.2017;3(1):22-30.
Gualano MR, Stillo M, Mussa MV, Zotti CM. Cross sectional study investigating the differences in knowledge and behaviors about HPV between vaccinated and non-vaccinated girls. Journal of preventive medicine and hygiene. 2016 Sep;57(3):E121
Abdi F, Simbar M. The peer education approach in adolescents-narrative review article. Iranian journal of public health. 2013 Nov;42(11):1200.
Adeomi AA, Adeoye OA, Asekun-Olarinmoye EO, Abodunrin OL, Olugbenga-Bello AI, Sabageh AO. Evaluation of the effectiveness of peer education in improving HIV knowledge, attitude, and sexual behaviours among in-school adolescents in Osun State, Nigeria. AIDS research and treatment. 2014 Nov 13;2014.
Sánchez-Alemán MA, Uribe-Salas FJ, Lazcano-Ponce EC, García-Cisneros S, Eguiza-Fano S, Conde-Glez CJ. HSV-2 seroincidence among Mexican college students: the delay of sexual debut is not enough to avoid risky sexual behaviours and virus transmission. Sexually transmitted infections. 2010 Dec 1;86(7):565-9.
Downloads
Published
Versions
- 2023-03-16 (2)
- 2023-03-11 (1)
How to Cite
Issue
Section
License
Copyright (c) 2023 Journal and Publisher
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The Journal is owned, published and copyrighted by the Nigerian Medical Association, River state Branch. The copyright of papers published are vested in the journal and the publisher. In line with our open access policy and the Creative Commons Attribution License policy authors are allowed to share their work with an acknowledgement of the work's authorship and initial publication in this journal.
This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author.
The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations. While the advice and information in this journal are believed to be true and accurate on the date of its going to press, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein.
TNHJ also supports open access archiving of articles published in the journal after three months of publication. Authors are permitted and encouraged to post their work online (e.g, in institutional repositories or on their website) within the stated period, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). All requests for permission for open access archiving outside this period should be sent to the editor via email to editor@tnhjph.com.
